Berkeley Capital Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.08M | Buy |
12,608
+4,492
| +55% | +$1.05M | 0.71% | 23 |
|
|
2025
Q4 | $1.68M | Buy |
8,116
+1,254
| +18% | +$248K | 0.4% | 49 |
|
|
2025
Q3 | $1.27M | Buy |
6,862
+134
| +2% | +$23K | 0.3% | 70 |
|
|
2025
Q2 | $1.03M | Sell |
6,728
-178
| -3% | -$27.4K | 0.26% | 81 |
|
|
2025
Q1 | $1.15M | Buy |
6,906
+187
| +3% | +$29.3K | 0.31% | 70 |
|
|
2024
Q4 | $972K | Sell |
6,719
-396
| -6% | -$61.4K | 0.27% | 78 |
|
|
2024
Q3 | $1.15M | Buy |
7,115
+541
| +8% | +$86.2K | 0.33% | 67 |
|
|
2024
Q2 | $961K | Buy |
6,574
+334
| +5% | +$49.7K | 0.29% | 70 |
|
|
2024
Q1 | $987K | Buy |
6,240
+100
| +2% | +$15.9K | 0.3% | 69 |
|
|
2023
Q4 | $962K | Sell |
6,140
-219
| -3% | -$33.6K | 0.32% | 66 |
|
|
2023
Q3 | $990K | Sell |
6,359
-6,636
| -51% | -$1.09M | 0.36% | 58 |
|
|
2023
Q2 | $2.15M | Buy |
12,995
+874
| +7% | +$141K | 0.76% | 22 |
|
|
2023
Q1 | $1.88M | Buy |
12,121
+246
| +2% | +$39.7K | 0.7% | 23 |
|
|
2022
Q4 | $2.1M | Buy |
11,875
+408
| +4% | +$70.4K | 0.81% | 22 |
|
|
2022
Q3 | $1.87M | Buy |
11,467
+4,853
| +73% | +$821K | 0.81% | 19 |
|
|
2022
Q2 | $1.17M | Buy |
6,614
+109
| +2% | +$19.4K | 0.48% | 36 |
|
|
2022
Q1 | $1.15M | Buy |
6,505
+17
| +0.3% | +$2.89K | 0.46% | 35 |
|
|
2021
Q4 | $1.11M | Buy |
6,488
+432
| +7% | +$70.7K | 0.46% | 31 |
|
|
2021
Q3 | $978K | Buy |
6,056
+277
| +5% | +$47.3K | 0.45% | 33 |
|
|
2021
Q2 | $952K | Buy |
5,779
+11
| +0.2% | +$1.82K | 0.42% | 34 |
|
|
2021
Q1 | $948K | Sell |
5,768
-940
| -14% | -$152K | 0.46% | 30 |
|
|
2020
Q4 | $1.06M | Sell |
6,708
-660
| -9% | -$97.4K | 0.54% | 27 |
|
|
2020
Q3 | $1.1M | Buy |
7,368
+819
| +13% | +$121K | 0.67% | 22 |
|
|
2020
Q2 | $921K | Sell |
6,549
-1,555
| -19% | -$227K | 0.57% | 27 |
|
|
2020
Q1 | $1.06M | Buy |
8,104
+349
| +5% | +$49.5K | 0.72% | 21 |
|
|
2019
Q4 | $1.13M | Buy |
7,755
+178
| +2% | +$24.1K | 0.58% | 35 |
|
|
2019
Q3 | $980K | Sell |
7,577
-982
| -11% | -$129K | 0.52% | 40 |
|
|
2019
Q2 | $1.19M | Sell |
8,559
-434
| -5% | -$60.1K | 0.56% | 31 |
|
|
2019
Q1 | $1.26M | Sell |
8,993
-1,194
| -12% | -$160K | 0.62% | 28 |
|
|
2018
Q4 | $1.31M | Sell |
10,187
-433
| -4% | -$60.4K | 0.73% | 23 |
|
|
2018
Q3 | $1.47M | Buy |
10,620
+2,604
| +32% | +$346K | 0.83% | 21 |
|
|
2018
Q2 | $972K | Buy |
8,016
+233
| +3% | +$29.1K | 0.57% | 40 |
|
|
2018
Q1 | $997K | Buy |
7,783
+3,185
| +69% | +$430K | 0.58% | 39 |
|
|
2017
Q4 | $642K | Sell |
4,598
-145
| -3% | -$20.2K | 0.42% | 62 |
|
|
2017
Q3 | $617K | Buy |
4,743
+187
| +4% | +$24.8K | 0.41% | 71 |
|
|
2017
Q2 | $603K | Sell |
4,556
-1,083
| -19% | -$138K | 0.41% | 59 |
|
|
2017
Q1 | $702K | Sell |
5,639
-2,854
| -34% | -$341K | 0.48% | 55 |
|
|
2016
Q4 | $979K | Sell |
8,493
-122
| -1% | -$14.1K | 0.71% | 32 |
|
|
2016
Q3 | $1.02M | Buy |
8,615
+3,019
| +54% | +$366K | 0.73% | 28 |
|
|
2016
Q2 | $679K | Sell |
5,596
-2,853
| -34% | -$324K | 0.48% | 47 |
|
|
2016
Q1 | $914K | Buy |
8,449
+471
| +6% | +$48.8K | 0.66% | 33 |
|
|
2015
Q4 | $820K | Buy |
+7,978
| New | +$802K | 0.67% | 34 |
|
Other funds holding JNJ
VCM
VPM
Berkeley Capital Partners's JNJ Position: Q1 2026 in Review
Berkeley Capital Partners increased its Johnson & Johnson (JNJ) stake by 55% in Q1 2026, buying an estimated $1.05M and bringing the position to 12,608 shares worth $3.08M. The position accounts for 0.71% of the portfolio, ranked #23.
Berkeley Capital Partners first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Berkeley Capital Partners held 12,608 shares of Johnson & Johnson worth $3.08M as of Q1 2026.
- Berkeley Capital Partners bought 4,492 Johnson & Johnson shares in Q1 2026, an estimated $1.05M.
- Johnson & Johnson made up 0.71% of Berkeley Capital Partners's portfolio in Q1 2026, its #23 holding.
- Berkeley Capital Partners first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Berkeley Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.